Dementias Platform UK (DPUK) is a world-leading resource for person-focused dementias research designed to fast-track scientific understanding, treatments and the prevention of the disease.
Established by the Medical Research Council (MRC) in June 2014, it is a £53 million collaboration between universities and pharmaceutical companies to transform the best dementia research into the best treatments as quickly as possible.
It combines the power of different types of population study to compare healthy people with people at all stages of dementias and can be used to look at how this is affected by other conditions that people may have.
We actively encourage leading researchers to work together, giving them better access to the wealth of information on health and lifestyle through huge population studies, and arming them with the latest technology, to scan the body and brain and analyse tests.
It also spearheads ‘experimental medicine’ research, which are ‘first in human’ studies, testing out new treatments, new devices, improvements in diagnoses for the first time in people and also looking at repurposing drugs – trying out treatments which are already on the market, but used for a different condition, to see how they might benefit those with dementia. DPUK forms a central pillar in the delivery of the UK Prime Minister’s Challenge on dementia.
DPUK coordinates 15 work packages, across three unique networks and three Experimental Medicine themes, involving hundreds of researchers across the UK and beyond.
These activities will:
We will find out:
We will develop new ways of:
We will support dementia research more widely through:
We will help people: